open access
Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction
open access
Abstract
Abstract
Keywords
intracoronary fibrinolysis, intramyocardial hemorrhage, microvascular obstruction, primary percutaneous coronary intervention
About this articleTitle
Effects of intracoronary antithrombotics on ventricular function: A comparison of tenecteplase versus abciximab during primary percutaneous intervention in myocardial infarction
Journal
Issue
Published online
2021-01-11
DOI
10.5603/CJ.a2021.0002
Pubmed
Keywords
intracoronary fibrinolysis
intramyocardial hemorrhage
microvascular obstruction
primary percutaneous coronary intervention
Authors
Francisco J. Morales-Ponce
Pablo González-Pérez
Sara Blasco-Turrión
Juan Antonio Sánchez-Brotons
Carmen Collado-Moreno
Pedro Martínez-Romero
Eduardo Martínez-Morentín
Pilar Caro-Mateo
References (4)- Stone GW, Maehara A, Witzenbichler B, et al. Intracoronary abciximab and aspiration thrombectomy in patients with large anterior myocardial infarction: the INFUSE-AMI randomized trial. JAMA. 2012; 307(17): 1817–1826.
- Morales-Ponce FJ, Lozano-Cid FJ, Martinez-Romero P, et al. Intracoronary tenecteplase versus abciximab as adjunctive treatment during primary percutaneous coronary intervention in patients with anterior myocardial infarction. EuroIntervention. 2019; 14(16): 1668–1675.
- Prastaro M, Pirozzi E, Gaibazzi N, et al. Expert review on the prognostic role of echocardiography after acute myocardial infarction. J Am Soc Echocardiogr. 2017; 30(5): 431–443.e2.
- McCartney PJ, Maznyczka AM, Eteiba H, et al. Low-Dose alteplase during primary percutaneous coronary intervention according to ischemic time. J Am Coll Cardiol. 2020; 75(12): 1406–1421.